Dianthus Therapeutics | MGTA - Market Capitalization

Stock Price
49.07
Daily Change
-3.39 -6.46%
Monthly
33.02%
Yearly
98.42%
Q1 Forecast
51.75

Dianthus Therapeutics reported $1.54B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.51T 297.32B Sep/2025
IQVIA Holdings USD 32.29B 5.03B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Moderna USD 10.09B 581M Sep/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 2.18B 593.28M Feb/2026
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.68B 12.64M Feb/2026
Revvity USD 13.23B 3.47B Feb/2026
Sartorius EUR 8.36B 8.04B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025